Recruiting Peripheral T-Cell Lymphoma Studies in Pittsburgh
About Peripheral T-Cell Lymphoma Clinical Trials in Pittsburgh
Peripheral T-cell lymphomas are a diverse group of aggressive non-Hodgkin lymphomas that develop from mature T-cells. They account for about 10-15% of all NHL cases. Treatment includes combination chemotherapy, stem cell transplant, and newer targeted agents.
There are currently 3 peripheral t-cell lymphoma clinical trials recruiting participants in Pittsburgh, PA. These studies are seeking a combined 346 participants. Research is being sponsored by University of Pittsburgh, University of Michigan Rogel Cancer Center, SciTech Development, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Peripheral T-Cell Lymphoma Clinical Trials in Pittsburgh — FAQ
Are there peripheral t-cell lymphoma clinical trials in Pittsburgh?
Yes, there are 3 peripheral t-cell lymphoma clinical trials currently recruiting in Pittsburgh, PA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Pittsburgh?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Pittsburgh research site will contact you about next steps.
Are clinical trials in Pittsburgh free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Pittsburgh studies also compensate for your time and travel.
What peripheral t-cell lymphoma treatments are being tested?
The 3 active trials in Pittsburgh are testing new therapies including novel drugs, biologics, and treatment approaches for peripheral t-cell lymphoma.
Data updated October 15, 2026 from ClinicalTrials.gov